Format

Send to

Choose Destination
Haemostasis. 1996;26 Suppl 1:155-8.

Treatment of factor VII deficiency with recombinant factor VIIa.

Author information

1
Hematology-Oncology Section, Department of Medicine, Brockton-West Roxbury, Harvard Medical School, Boston, Masschusetts, USA.

Abstract

Factor VII deficiency is a relatively infrequent hereditary bleeding disorder. Recombinant factor VIIa has been used to treat patients with factor VII deficiency with bleeding episodes or undergoing surgery. The drug has shown a high efficacy rate and will provide factor VII-deficient patients with a therapeutic agent that is not derived from human plasma.

PMID:
8904192
DOI:
10.1159/000217259
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center